A CVS Health subsidiary, Omnicare, is facing a lawsuit from the Department of Justice over allegations the company defrauded government health programs by providing prescription drugs to thousands of long-term care facilities without proper prescriptions.

HHS has issued a set of two proposed rules aimed at improving the availability of organs for the 113,000 Americans on waitlists for transplants.

The Department of Justice will probe Google’s $2.1 billion acquisition of wearables company Fitbit, The New York Post reported, citing a source close to the situation.

Digital investments are top of mind for health systems leaders in 2020, according to a new report from PwC Health Research Institute.

Lawmakers have come to an agreement to stop surprise medical billing in new legislation that would also enact a number of other healthcare initiatives. The bipartisan agreement could put an end to the legislative stalemate on Capitol Hill in light of President Trump's impeachment proceedings. 

A group of prominent hospital associations have filed a lawsuit against HHS to stop the implementation of a rule that requires hospitals to post their prices for services online and update it regularly.

The pharmaceutical industry could be in for a loss as the Trump administration considers easing patent protection rules in order to garner support from Democrats for a new trade pact between the U.S., Mexico and Canada­––USMCA, The Wall Street Journal reported.

HHS has announced a new initiative to make a medication taken to prevent HIV, pre-exposure prophylaxis, or PrEP, available for free to those without prescription drug insurance coverage.

Hospitals were overpaid by roughly $502 million from 2011 to 2014, according to a report from the Office of Inspector General (OIG), which blamed the overpayment on CMS limitations on the reconciliation period.

President Trump’s plan to allow the importation of certain drugs from Canada is facing new challenges from the Canadian government, according to The Hill.

 

Pharmaceutical companies are under fire again for their role in the national opioid abuse epidemic, and this time, it could be criminal. Federal prosecutors have opened a criminal probe to determine if pharmaceutical companies intentionally allowed the flow of opioid drugs, The Wall Street Journal reported.

CMS issued more details and opened up applications for its upcoming direct contracting models that draw lessons from accountable care organizations and aim to promote shared risk.